Ignite Creation Date:
2024-07-17 @ 11:42 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06500377
Status:
RECRUITING
Last Update Posted:
2024-07-15
First Post:
2024-07-09
Brief Title:
Comparing the Impact of Four Types of Meditation Practices for Relaxation in Cancer Survivors
Sponsor:
City of Hope Medical Center
Organization:
City of Hope Medical Center
Study Overview
Official Title:
A Pilot Study Exploring Four Types of Meditation Practices for Relaxation Among Cancer Survivors
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This clinical trial compares the impact of four types of meditation practices breathing only focused attention only mindfulness only and breathing focused attention and mindfulness combined for relaxation in cancer survivors Studies show that many patients with cancer experience stress and anxiety Meditation therapy uses a variety of techniques such as breathing sound or movement that may help to decrease distress and anxiety and enhance the health and quality of life of patients with cancer The trial is being done to find out how meditation can help cancer survivors feel relaxed and attain a peaceful state of mind
Detailed Description:
PRIMARY OBJECTIVE
I Assess the feasibility to attend and complete the meditation program as scheduled combined arms within six weeks
EXPLORATORY OBJECTIVES
I Assess the ability of breathing mindfulness focused attention and a combination of all three meditation techniques to enhance relaxation in cancer survivors
II Determine which meditation technique improves the outcome measures the most
III Explore which meditation method is preferred by the subjects
OUTLINE Patients are randomized to 1 of 4 arms
ARM I Patients learn breathing only meditation with an instructor over 60 minutes for 3 sessions within 6 weeks Patients also practice meditation at home and undergo saliva sample collection on study
ARM II Patients learn focused attention only meditation with an instructor over 60 minutes for 3 sessions within 6 weeks Patients also practice meditation at home and undergo saliva sample collection on study
ARM III Patients learn mindfulness only meditation with an instructor over 60 minutes for 3 sessions within 6 weeks Patients also practice meditation at home and undergo saliva sample collection on study
ARM IV Patients learn breathing focused attention and mindfulness combined meditation with an instructor over 60 minutes for 3 sessions within 6 weeks Patients also practice meditation at home and undergo saliva sample collection on study
I Assess the feasibility to attend and complete the meditation program as scheduled combined arms within six weeks
EXPLORATORY OBJECTIVES
I Assess the ability of breathing mindfulness focused attention and a combination of all three meditation techniques to enhance relaxation in cancer survivors
II Determine which meditation technique improves the outcome measures the most
III Explore which meditation method is preferred by the subjects
OUTLINE Patients are randomized to 1 of 4 arms
ARM I Patients learn breathing only meditation with an instructor over 60 minutes for 3 sessions within 6 weeks Patients also practice meditation at home and undergo saliva sample collection on study
ARM II Patients learn focused attention only meditation with an instructor over 60 minutes for 3 sessions within 6 weeks Patients also practice meditation at home and undergo saliva sample collection on study
ARM III Patients learn mindfulness only meditation with an instructor over 60 minutes for 3 sessions within 6 weeks Patients also practice meditation at home and undergo saliva sample collection on study
ARM IV Patients learn breathing focused attention and mindfulness combined meditation with an instructor over 60 minutes for 3 sessions within 6 weeks Patients also practice meditation at home and undergo saliva sample collection on study
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NCI-2024-04827 | REGISTRY | None | None |
| 22607 | OTHER | None | None |
| P30CA033572 | NIH | None | None |